Long-term prognostic impact of beta-blockers in patients with Takotsubo syndrome: Results from the RETAKO Registry

Long-term prognostic impact of beta-blockers in patients with Takotsubo syndrome: Results from the RETAKO Registry

Background: No evidence-based therapy has yet been established for Takotsubo syndrome (TTS). Given the putative harmful effects of catecholamines in patients with TTS, beta-blockers may potentially decrease the intensity of the detrimental cardiac effects in those patients. Objective: The purpose of...

Full description

Bibliographic Details
Main Authors: Sergio Raposeiras-Roubín, Iván J. Núñez-Gil, Karim Jamhour, Emad Abu-Assi, David Aritza Conty, Oscar Vedia, Manuel Almendro-Delia, Alessandro Sionis, Agustin C. Martin-Garcia, Miguel Corbí-Pascual, Manuel Martínez-Sellés, Aitor Uribarri, Marta Guillén, José María García Acuña, Javier Lopez País, Emilia Blanco, José A. Linares Vicente, Alejandro Sánchez Grande Flecha, Mireia Andrés, Alberto Pérez-Castellanos, Joaquín Alonso, Xavier Rosselló, Andrés Iñiguez Romo, Gisela Feltes
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Revista Portuguesa de Cardiologia
Subjects:
Takotsubo
Betabloqueante
Mortalidade
Recorrência
Online Access:http://www.sciencedirect.com/science/article/pii/S0870255123000458

Internet

http://www.sciencedirect.com/science/article/pii/S0870255123000458

Similar Items